Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57 | 10 | 517 | 1,542 | 159 |
| Receivables | N/A | 34 | N/A | 2 | 28 |
| TOTAL | $281 | $410 | $1,023 | $1,635 | $437 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 278 | 293 | 308 | 8 | 59 |
| TOTAL | $278 | $293 | $308 | $8 | $59 |
| Total Assets | $560 | $703 | $1,331 | $1,643 | $496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,709 | 1,362 | 1,095 | 742 | 1,279 |
| Accrued Expenses | 1,685 | 66 | 1,290 | 1,162 | 1,233 |
| Other current liabilities | 15 | 34 | 29 | N/A | 45 |
| TOTAL | $3,614 | $2,960 | $2,613 | $2,042 | $2,579 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12 | 47 | 82 | 116 | N/A |
| Other Non-Current Liabilities | 220 | 238 | 254 | 0 | 0 |
| TOTAL | $232 | $285 | $336 | $116 | $N/A |
| Total Liabilities | $3,846 | $3,244 | $2,949 | $2,158 | $2,579 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,889 | 3,817 | 3,814 | 3,759 | 3,546 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -143,851 | -142,818 | -141,178 | -136,967 | -135,365 |
| TOTAL | $-3,287 | $-2,541 | $-1,617 | $-515 | $-2,083 |
| Total Liabilities And Equity | $560 | $703 | $1,331 | $1,643 | $496 |